The benefit of betrixaban for the extended thromboprophylaxis in acutely ill medical patients
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1558209
Abstract: ABSTRACT Introduction: Patients admitted with acute medical conditions are at prolonged risk for venous thrombosis. The efficacy and safety, and the appropriate duration of thromboprophylaxis have not been clearly determined. In recent years, direct coagulation… read more here.
Keywords: acutely ill; ill medical; extended thromboprophylaxis; thromboprophylaxis acutely ... See more keywords
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials
Sign Up to like & getrecommendations! Published in 2022 at "Circulation"
DOI: 10.1161/circulationaha.121.057847
Abstract: Background: Extended thromboprophylaxis has not been widely implemented in acutely ill medical patients because of bleeding concerns. The MAGELLAN (Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized… read more here.
Keywords: ill patients; major bleeding; extended thromboprophylaxis; risk ... See more keywords
Extended Thromboprophylaxis in Patients with COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Blood"
DOI: 10.1182/blood-2021-149566
Abstract: Introduction Patients hospitalized with COVID-19 have an increased incidence of venous thromboembolism (VTE) and arterial thromboembolism (ATE) events. These thrombotic events increase readmission and mortality rate in COVID-19 survivors who are recently discharged from hospital.… read more here.
Keywords: discharge; covid; post discharge; extended thromboprophylaxis ... See more keywords